BREAKING: FDA Approves Trials for Cannabis-Based Epilepsy Medicine

The U.S. Federal Drug Administration has given unprecedented approval for two separate trials of Epidiolex, a liquid medicine made entirely of cannabis; the substance contains 98% cannafdabidiol, a nonpsychoactive compound found in cannabis – the remaining 2% consist of various trace amounts of other cannabinoids.

The studies will be led by Orrin Devinsky, MD at New York University’s School of Medicine, and Roberta Cilio, MD, PhD, at the University of California.

Each study will involve 25 participants, all children.

Read moreBREAKING: FDA Approves Trials for Cannabis-Based Epilepsy Medicine